JESSICA D. JENSEN - 01 Apr 2022 Form 4 Insider Report for POINT Biopharma Global Inc. (PNT)

Role
EVP Clinical Development
Signature
/s/ William L. Demers, by Power of Attorney for Jessica D. Jensen
Issuer symbol
PNT
Transactions as of
01 Apr 2022
Net transactions value
$0
Form type
4
Filing time
05 Apr 2022, 10:48:56 UTC
Previous filing
31 Mar 2022
Next filing
30 Mar 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PNT Stock Option (Right to Buy) Award $0 +13,766 $0.000000 13,766 01 Apr 2022 Common Stock 13,766 $7.91 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests 25% on the first anniversary of the date of grant with the remaining 75% vesting in three equal annual installments thereafter.